ABT
All
Newsflash
Article
-
Abbott Laboratories (ABT) Q3 Earnings: EPS of $1.42 in line with expectations, revenue of $13.01 billion beats expectations.
EPS: $1.42, market expectation $1.42 Revenue: $13.01 billion, market expectation $12.99 billion Reporting period: Q3 FY2026 (ended September 30, 2026) Release date: October 21, 2026
-
Abbott Laboratories (ABT) Q3 Earnings: EPS of $1.42 in line with expectations, revenue of $13.01 billion beats expectations.
EPS: $1.42, market expectation $1.42 Revenue: $13.01 billion, market expectation $12.99 billion Reporting period: Q3 FY2026 (ended September 30, 2026) Release date: October 21, 2026
- No data
ABT
Svmuu provides news and information related to ABT, as well as real-time data on ABT. We provide in-depth analysis and interpretation of the latest ABT developments, helping investors stay informed about ABT policy updates. Svmuu is your essential tool for keeping up with the latest ABT trends! Here, we’ll join you in keeping a close eye on ABT news and use a clear macro perspective to make sense of the uncertain future of crypto.
24H Trending
-
1
Oracle, Meta, and SpaceX credit default swaps (CDS) hit all-time highs, as the market anticipates a surge in AI-related bond issuance in Q4.
-
2
Liu Jun, President of Industrial and Commercial Bank of China (ICBC): Commercial Banks Bear Heavier Financial and Legal Responsibilities Than Central Banks in AI Deployment
-
3
Bain Survey: Chinese Consumers Prioritize Technology in Car Purchases, While Europeans and Americans Still Value Price; Western Automakers Face Dual Pressure
-
4
Anthropic pitches AI safety bill that would require judge's permission to block models
-
5
Anthropic reportedly faces a compute shortage as cloud giants view it as a competitor, plans November IPO.
-
6
Media reports: Amazon Web Services (AWS) has billions of dollars worth of NVIDIA chips backlogged in its warehouses due to power shortages, leading to negative free cash flow.
-
7
Hansoh Pharmaceutical inks up to $15B drug deal with Roche, China's innovative drug out-licensing hits $130B
-
8
U.S. equity index futures rose, boosted by strong earnings reports from AI-related companies.
-
9
King Charles III of the UK praised Oman's peaceful efforts in reopening the Strait of Hormuz.
-
10
Multi-party talks between the US and Ukraine were held in Oslo, Norway, with the Finnish President stating "real progress has been made." Russia hopes to meet with the US envoy on the 21st.
Markets Today
Recommended Reading
